Related Experiment Video
Updated: Apr 22, 2026

06:16
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
14.9K
Protein kinase C in T-cell regulation
1Institut für Immunologie und Genetik, Deutsches Krebsforschungszentrum, D-6900 Heidelberg, FR Germany.
Immunology Today
|October 8, 2014
Summary
Protein kinase C (PKC) activation in T cells has complex effects. This review discusses its positive and negative impacts on T cell proliferation and function.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- T cell activation involves receptor-ligand binding, leading to phosphatidylinositol phosphate hydrolysis.
- This process generates diacylglycerol, a key activator of Protein Kinase C (PKC).
Purpose of the Study:
- To review the multifaceted consequences of PKC activation in T cells.
- To elucidate the dual roles of PKC in T cell proliferation and functional responses.
Main Methods:
- Literature review and synthesis of existing research on PKC signaling in T cells.
- Discussion of biochemical pathways and cellular outcomes related to PKC activation.
Main Results:
- PKC activation exhibits both stimulatory and inhibitory effects on T cell proliferation.
- PKC plays a complex role in the functional activation of both helper and cytotoxic T cells.
Conclusions:
- PKC signaling is a critical but complex regulator of T cell activation.
- Understanding these dual roles is essential for comprehending T cell-mediated immunity.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
7.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
Amplifying Signals via Enzymatic Cascade
14.9K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
The JAK-STAT Signaling Pathway
10.1K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.1K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity
4.3K
4.3K

